SAN DIEGO, Sept. 25, 2019 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced the Company will
highlight its enabling technologies at the North American Spine
Society (NASS) Annual Meeting, September
25-28, 2019 at McCormick Place in Chicago.
"As part of NuVasive's commitment to transform surgery, at NASS
we will showcase enabling technologies that help surgeons perform
less invasive spine procedures," said Matt
Link, president of NuVasive. "Key to this foundation is
Pulse, the first and only system to integrate multiple technologies
in a single expandable platform designed for all spine procedures.
As part of this platform, we look forward to unveiling Pulse
Robotics, an application that introduces automation while
maintaining surgeon control to optimize clinical decision making
and deliver better patient outcomes."
NuVasive's booth #2411 will feature the X360™ system, a
comprehensive approach to lateral single-position surgery, powered
by the Pulse® platform. The Company will also showcase its
comprehensive Advanced Materials Science® implant portfolio, which
now includes cervical offerings and a full portfolio for all TLIF
procedures, and Reline® fixation system updates along with other
procedural technologies. NuVasive will unveil its Pulse Robotics
application at an invitation-only event and host hands-on
demonstrations in a private technology suite, showcasing how Pulse
Robotics seamlessly integrates with the Pulse platform.
More about Pulse and Pulse Robotics:
The Pulse platform is an integrated technology system designed
to improve a surgeon's ability to utilize minimally invasive
surgical techniques, which have been shown to reduce blood loss,
hospital stays and result in less operative morbidity compared to
open spine surgery. The Pulse platform combines multiple
enabling technologies to improve workflow, reduce variability, and
increase the reproducibility of surgical outcomes, including
neuromonitoring, surgical planning, rod bending, radiation
reduction, imaging and navigation functions.
The Pulse platform's modular architecture was developed to be
expandable to allow for future technology applications, including
robotics and smart tools.1 The Pulse Robotics
application has been designed to allow surgeons to perform
robotic-assisted spine surgery with some key features,
including:
- An extensible architecture to support multiple procedural
applications, including X360 and posterior screw placement;
- Allows for optimized surgeon control with real-time adjustments
to enhance autonomy;
- Dynamic, real-time feedback, leveraging other applications on
the Pulse platform to facilitate clinical decision making; and
- A flexible mobile cart that is efficient to set up and
configures to the existing operating room.
NuVasive's development of Pulse with Pulse Robotics is part of
the Company's commitment to provide surgeons with enabling
technologies that help improve the standard of spine care through
less invasive surgery.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA)
is the leader in spine technology innovation, focused on
transforming spine surgery and beyond with minimally disruptive,
procedurally integrated solutions designed to deliver reproducible
and clinically-proven surgical outcomes. The Company's portfolio
includes access instruments, implantable hardware, biologics,
software systems for surgical planning, navigation and imaging
solutions, magnetically adjustable implant systems for spine and
orthopedics, and intraoperative monitoring service offerings. With
more than $1 billion in revenues,
NuVasive has approximately 2,600 employees and operates in more
than 50 countries serving surgeons, hospitals and patients. For
more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could cause NuVasive's
results to differ materially from historical results or those
expressed or implied by such forward-looking statements. The
potential risks and uncertainties which contribute to the uncertain
nature of these statements include, among others, risks associated
with acceptance of the Company's surgical products and procedures
by spine surgeons, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products (including the
iGA® platform), the Company's ability to effectually manage
inventory as it continues to release new products, its ability to
recruit and retain management and key personnel, and the other
risks and uncertainties described in NuVasive's news releases and
periodic filings with the Securities and Exchange Commission.
NuVasive's public filings with the Securities and Exchange
Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
1 Certain applications of the Pulse platform are
under development and not available for commercial sale; robotics
and smart tools are not cleared for use by the FDA.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvasive-to-demonstrate-enabling-technologies-to-accelerate-the-adoption-of-less-invasive-spine-surgery-at-nass-2019-300924851.html
SOURCE NuVasive, Inc.